THY1 and breast cancer: A pro-oncogenic role for miR-31 in breast cancer has been proposed, since it was found enriched in mammary stem cells (MaSC) and breast tumors, and appears to be essential for maintaining mammary tumor stem cells (CD24+/CD90+) in the MMTV-PyVT mice model [68].